AIP
IMMU

Ameritas Investment Partners’s Immunomedics Inc IMMU Stock Holding History

Ameritas Investment Partners’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,477
Closed -$222K – 3208
2020
Q1 		$222K Buy
16,477
+1,100
+7% +$18.5K 0.01% 886
2019
Q4 		$325K Buy
15,377
+424
+3% +$7.48K 0.01% 866
2019
Q3 		$198K Hold
14,953
– – 0.01% 1062
2019
Q2 		$207K Buy
14,953
+2,760
+23% +$41.5K 0.01% 1040
2019
Q1 		$234K Buy
12,193
+500
+4% +$8.06K 0.01% 969
2018
Q4 		$167K Hold
11,693
– – 0.01% 1063
2018
Q3 		$244K Buy
11,693
+705
+6% +$16.7K 0.01% 981
2018
Q2 		$260K Buy
10,988
+2,274
+26% +$45.7K 0.01% 935
2018
Q1 		$127K Buy
8,714
+500
+6% +$8.17K 0.01% 1345
2017
Q4 		$133K Hold
8,214
– – 0.01% 1334
2017
Q3 		$103K Hold
8,214
– – ﹤0.01% 1447
2017
Q2 		$73K Buy
8,214
+1,400
+21% +$9.83K ﹤0.01% 1661
2017
Q1 		$44K Buy
+6,814
New +$34.5K ﹤0.01% 1943

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Ameritas Investment Partners's IMMU Position: Q2 2020 in Review

Ameritas Investment Partners sold out of Immunomedics Inc (IMMU) in Q2 2020, closing a stake of 16,477 shares — an estimated $222K sold.

Ameritas Investment Partners first reported a position in IMMU in Q1 2017 and held it in 13 quarters. The position peaked at $325K in Q4 2019. 313 funds tracked by Wall St. Rank hold IMMU as of Q2 2020.

  • Ameritas Investment Partners reported no remaining Immunomedics Inc position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Partners sold 16,477 Immunomedics Inc shares in Q2 2020, an estimated $222K.
  • Ameritas Investment Partners first reported a position in Immunomedics Inc in Q1 2017 and held it in 13 quarters.
  • Ameritas Investment Partners's Immunomedics Inc position peaked at $325K in Q4 2019.
  • 313 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2020.

Based on Ameritas Investment Partners's 13F filing for Q2 2020, filed 5 Aug 2020.